www.newyorker.com
Open in
urlscan Pro
151.101.0.239
Public Scan
URL:
https://www.newyorker.com/science/annals-of-medicine
Submission: On September 09 via api from US — Scanned from DE
Submission: On September 09 via api from US — Scanned from DE
Form analysis
3 forms found in the DOM<form id="mainHeaderNewsletter" class="NewsletterCallout__newsletterForm___KelJX" autocomplete="on">
<div>Get the best of <em>The New Yorker</em> in your in-box every day.</div>
<div class="NewsletterCallout__email___YjWMa">
<div class="Input__inputContainer___3ZRfk"><input type="email" autocomplete="on" class="Input__input___2fcvD " name="email" placeholder="Enter your e-mail"><button class="Input__inputButton___2--U_" type="submit">Submit</button></div>
</div>
<div class="NewsletterCallout__privacy___2y2OX"><a class="Link__link___3dWao " href="https://www.condenast.com/privacy-policy#privacypolicy">Privacy Policy</a></div><input type="hidden" name="newsletterIds" value="217">
</form>
<form>
<div><input type="text" id="search-input-menu" placeholder="Search">
<div class="SearchInput__modalIcon___YSkrm">
<i class="SearchInput__modalIcon___YSkrm"><svg viewBox="0 0 18 18" xmlns="http://www.w3.org/2000/svg"><path d="M2 7.5C2 4.468 4.468 2 7.5 2S13 4.468 13 7.5 10.532 13 7.5 13 2 10.532 2 7.5zm16 9.086l-4.545-4.545C14.42 10.779 15 9.208 15 7.5 15 3.364 11.636 0 7.5 0S0 3.364 0 7.5 3.364 15 7.5 15c1.708 0 3.279-.58 4.541-1.545L16.586 18 18 16.586z" fill="#121212" fill-rule="evenodd"></path></svg></i>
</div>
</div>
</form>
<form id="mobilenav" class="NewsletterCallout__newsletterForm___KelJX" autocomplete="on">
<div>Get the best of <em>The New Yorker</em> in your in-box every day.</div>
<div class="NewsletterCallout__email___YjWMa">
<div class="Input__inputContainer___3ZRfk"><input type="email" autocomplete="on" class="Input__input___2fcvD " name="email" placeholder="Enter your e-mail"><button class="Input__inputButton___2--U_" type="submit">Submit</button></div>
</div>
<div class="NewsletterCallout__privacy___2y2OX"><a class="Link__link___3dWao " href="https://www.condenast.com/privacy-policy#privacypolicy">Privacy Policy</a></div><input type="hidden" name="newsletterIds" value="217">
</form>
Text Content
Subscribe and get a free tote. » The New Yorker Newsletter Get the best of The New Yorker in your in-box every day. Submit Privacy Policy Sign in Shop * News * Books & Culture * Fiction & Poetry * Humor & Cartoons * Magazine * Puzzles & Games * Video * Podcasts * Archive * Goings On * Subscribe The New Yorker ANNALS OF MEDICINE * CAN WE PREDICT WHICH VIRUSES WILL SPREAD FROM ANIMALS TO HUMANS? COVID, MONKEYPOX, EBOLA, AND SARS ALL ORIGINATED IN ANIMALS. SOME RESEARCHERS THINK WE CAN PREDICT WHAT’S NEXT, WHILE OTHERS BELIEVE IT’S AN IMPOSSIBLE TASK. By Matthew Hutson SEPTEMBER 2, 2022 * THE PREVENTABLE TRAGEDY OF POLIO IN NEW YORK POLIO IS ONE OF THE FEW DISEASES THAT CAN BE ERADICATED—BUT FALTERING VACCINATION RATES COULD UNDO YEARS OF HARD-WON GLOBAL PROGRESS. By Dhruv Khullar AUGUST 22, 2022 * WHY A LIFE-THREATENING PREGNANCY COMPLICATION IS ON THE RISE THE RATE OF PREECLAMPSIA HAD BEEN CLIMBING STEADILY FOR YEARS. THEN COVID-19 ARRIVED, AND THE NUMBERS SPIKED. By Jessica Winter AUGUST 12, 2022 * THE COMPLICATED LIFE OF THE ABORTION PILL A FRENCH DOCTOR’S INVENTION AND POST-ROE AMERICA. By Lauren Collins JULY 5, 2022 * WAITING AT A TEXAS HOSPITAL FOR CHILDREN WHO NEVER ARRIVE WE WANTED TO HAVE NEVER HEARD OF THEM, BUT THEN WE WANTED THEM HERE. By Rachel Pearson MAY 27, 2022 * WHAT THE “LIFE OF THE MOTHER” MIGHT MEAN IN A POST-ROE AMERICA “WE ARE GOING TO SEE MORE DEATHS AND MORE INJURIES,” GHAZALEH MOAYEDI, AN OB-GYN IN DALLAS, SAID. “I DON’T HAVE TO SPECULATE ABOUT THAT AT ALL.” By Jessica Winter MAY 12, 2022 * ARE WE ABOUT TO CURE SICKLE-CELL DISEASE? NEW GENE THERAPIES HOLD EXTRAORDINARY PROMISE, BUT THEY MIGHT NOT BE ENOUGH TO OVERCOME A MEDICAL SYSTEM THAT MARGINALIZES BLACK AMERICANS. By Dhruv Khullar MARCH 22, 2022 * INSIDE THE AMERICAN MEDICAL ASSOCIATION’S FIGHT OVER SINGLE-PAYER HEALTH CARE A LONG-STANDING BATTLE HIGHLIGHTS A PROFESSION’S POLITICAL TRANSFORMATION. By Clifford Marks FEBRUARY 22, 2022 * BEYOND THE BOOSTER SHOT COULD A “BROAD SPECTRUM” BOOSTER INCREASE OUR IMMUNITY TO MANY PATHOGENS SIMULTANEOUSLY? By Matthew Hutson FEBRUARY 8, 2022 * COULD ONE SHOT KILL THE FLU? A “UNIVERSAL” FLU VACCINE COULD BRING ONE OF THE WORLD’S LONGEST PANDEMICS TO AN END. By Matthew Hutson NOVEMBER 22, 2021 * A DOCTOR, A PATIENT, AND THEIR POETRY IN SOME WAYS, WRITING WAS THE BEST TREATMENT. By Ofole Mgbako NOVEMBER 10, 2021 * MEDICINE’S WELLNESS CONUNDRUM PATIENTS WANT ALTERNATIVE THERAPIES. HOW CAN HOSPITALS OFFER THEM WITHOUT PUTTING MEDICAL INTEGRITY AT RISK? By Jessica Wapner NOVEMBER 6, 2021 * THE TWO-DECADE DELAY IN LYME-DISEASE VACCINES INITIALLY HALTED BY PUBLIC FEARS, A PREVENTIVE TREATMENT COULD BE HERE IN TWO YEARS. By Sue Halpern AUGUST 19, 2021 * HOW WILL THE CORONAVIRUS EVOLVE? DELTA WON’T BE THE LAST VARIANT. WHAT WILL THE NEXT ONES BRING? By Dhruv Khullar AUGUST 11, 2021 * COEXISTING WITH THE CORONAVIRUS COVID-19 IS LIKELY TO BECOME AN ENDEMIC DISEASE. HOW WILL OUR IMMUNE SYSTEMS RESIST IT? By Katherine S. Xue JULY 21, 2021 * HEIDI LARSON, VACCINE ANTHROPOLOGIST THE WORLD’S RICHEST COUNTRIES ARE NOW ITS MOST VACCINE-HESITANT. CAN WE LEARN TO TRUST OUR SHOTS BEFORE THE NEXT PANDEMIC? By Danielle Ofri JUNE 12, 2021 * WHAT WILL IT TAKE TO PANDEMIC-PROOF AMERICA? WHEN THE NEXT VIRUS STRIKES, WE’LL LOOK BACK ON THIS MOMENT AS AN OPPORTUNITY THAT WE EITHER SEIZED OR SQUANDERED. By Dhruv Khullar APRIL 15, 2021 * THE LAST TIME A VACCINE SAVED AMERICA SIXTY-SIX YEARS AGO, PEOPLE CELEBRATED THE POLIO VACCINE BY EMBRACING IN THE STREETS. OUR VACCINE STORY IS BOTH MORE EXTRAORDINARY AND MORE COMPLICATED. By Howard Markel APRIL 12, 2021 * WHY COVID-19 VACCINES AREN’T YET AVAILABLE TO EVERYONE PRESIDENT BIDEN HAS PROMISED THAT ALL ADULTS WILL BE ELIGIBLE TO RECEIVE A VACCINE BY MAY. BUT MANUFACTURING AND DISTRIBUTING ENOUGH DOSES WILL DEPEND ON A LOT OF THINGS GOING RIGHT. By Sue Halpern MARCH 13, 2021 * ATUL GAWANDE ON CORONAVIRUS VACCINES AND PROSPECTS FOR ENDING THE PANDEMIC THE NEW YORKER STAFF WRITER, NOW A MEMBER OF PRESIDENT-ELECT BIDEN’S COVID-19 ADVISORY BOARD, DISCUSSES WHEN A VACCINE MIGHT BE READY FOR DISTRIBUTION, WHO SHOULD RECEIVE IT, AND WHETHER ERADICATING THE VIRUS IS POSSIBLE. By David Remnick DECEMBER 4, 2020 * 1 LISTEN TO THE NEW YORKER RADIO HOUR BUY THE COVER PLAY THE CROSSWORD PLAY THE JIGSAW PUZZLE NEWS & POLITICS * Daily Comment * Our Columnists * News Desk CULTURE * Cultural Comment * Culture Desk * Goings On About Town * The Critics BUSINESS, SCIENCE & TECH * Currency * Elements HUMOR * Daily Shouts * Shouts & Murmurs * The Borowitz Report CARTOONS * Daily Cartoon * Cartoon Caption Contest * Cartoon Bank BOOKS & FICTION * Page-Turner * Books * Poems * Fiction MAGAZINE * This Week's Issue * Archive * Subscribe PHOTOGRAPHY * Photo Booth * Portfolio VIDEO * Culture * Humor * News * Politics * Science & Tech * Sports PODCASTS * The New Yorker Radio Hour * Political Scene * The Writer's Voice * Fiction * Poetry MORE * Customer Care * Shop The New Yorker * Buy Covers and Cartoons * Condé Nast Store * Digital Access * Crossword Puzzle * Jigsaw Puzzle * RSS * Site Map NEWSLETTERS * The Daily * The New Yorker Recommends * Daily Humor * John Cassidy * The Borowitz Report * Amy Davidson Sorkin * Election 2020 * Food ABOUT US * About * Careers * Contact * F.A.Q * Media Kit * Press * Accessibility Help SectionsNews & PoliticsCultureBusiness, Science & TechHumorCartoonsBooks & FictionMagazinePhotographyVideoPodcastsMoreNewsletters AboutCareersContactF.A.QMedia KitPressAccessibility Help FOLLOW US Manage Preferences © 2022 Condé Nast. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement (updated as of 1/1/21) and Privacy Policy and Cookie Statement (updated as of 1/1/21). Your California Privacy Rights. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Condé Nast. The New Yorker may earn a portion of sales from products and services that are purchased through links on our site as part of our affiliate partnerships with retailers. Ad Choices Our sitesAllureArs TechnicaBackchannelBon AppétitCondé Nast TravelerEpicuriousGlamourGQGQ StylePitchforkSelfStyleTeen VogueThe New YorkerThe SceneVanity FairVogueWired Sign in Shop * News * Books & Culture * Fiction & Poetry * Humor & Cartoons * Magazine * Puzzles & Games * Video * Podcasts * Archive * Goings On Get the best of The New Yorker in your in-box every day. Submit Privacy Policy WE CARE ABOUT YOUR PRIVACY We and our partners store and/or access information on a device, such as unique IDs in cookies to process personal data. You may accept or manage your choices by clicking below or at any time in the privacy policy page. These choices will be signaled to our partners and will not affect browsing data. WE AND OUR PARTNERS PROCESS DATA TO PROVIDE: Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised ads and content, ad and content measurement, audience insights and product development. List of Partners (vendors) I Accept Show Purposes